Immunodiagnostic Systems Hldgs PLC PT Raised to GBX 500 (IDH)
Investment analysts at FinnCap increased their price target on shares of Immunodiagnostic Systems Hldgs PLC (LON:IDH) from GBX 450 ($7.69) to GBX 500 ($8.54) in a note issued to investors on Wednesday. The firm currently has a “hold” rating on the stock. FinnCap’s price objective suggests a potential downside of 5.12% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Tuesday, June 24th. They now have a GBX 504 ($8.61) price target on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of Immunodiagnostic Systems Hldgs PLC from GBX 459 ($7.84) to GBX 492 ($8.41) in a research note on Thursday, June 19th. They now have a “hold” rating on the stock. Finally, analysts at Nplus1 Brewin reiterated a “hold” rating on shares of Immunodiagnostic Systems Hldgs PLC in a research note on Wednesday, April 30th. They now have a GBX 504 ($8.61) price target on the stock. Six investment analysts have rated the stock with a hold rating, Immunodiagnostic Systems Hldgs PLC currently has a consensus rating of “Hold” and a consensus target price of GBX 500.67 ($8.56).
Shares of Immunodiagnostic Systems Hldgs PLC (LON:IDH) traded up 0.67% on Wednesday, hitting GBX 527.00. The stock had a trading volume of 3,954 shares. Immunodiagnostic Systems Hldgs PLC has a 52 week low of GBX 405.00 and a 52 week high of GBX 593.00. The stock’s 50-day moving average is GBX 528.0 and its 200-day moving average is GBX 529.6.
The company also recently declared a dividend, which is scheduled for Friday, August 22nd. Stockholders of record on Wednesday, July 23rd will be given a dividend of GBX 8.50 ($0.15) per share. This represents a yield of 1.57%. The ex-dividend date of this dividend is Wednesday, July 23rd.
Immunodiagnostic Systems Holdings plc (LON:IDH) is engaged in manufacturing and distributing medical diagnostic products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.